Clinical trial
Establish MeMed BV™ Performance for Differentiating Bacterial From Viral…
NCT04690569 · MeMed Diagnostics Ltd., Industry · Completed
Key facts
| NCT number | NCT04690569 |
|---|---|
| Title | Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY) |
| Official title | Prospective, Multi-Center, Observational, Blinded Study to Establish the Diagnostic Performance of the MeMed BV™ Test for Differentiating Bacterial From Viral Infection in Patients With Suspected Acute Bacterial or Viral Infection ("APOLLO" STUDY) |
| Acronym | Apollo |
| Lead sponsor | MeMed Diagnostics Ltd., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Acute Infection |
| Intervention type | Diagnostic Test |
| Interventions | MeMed BV |
| Enrollment | 1,384 |
| Start date | May 3, 2019 |
| Primary completion | Nov 22, 2020 |
| Completion | Nov 22, 2020 |
| First posted | Dec 30, 2020 |
| Last update posted | Jan 5, 2021 |
| Countries | Israel, United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: